Neuroticism and Addiction: Substance Use, Negative Affect, and Risk
Author: Ukrainian Psychological Hub · Published: September 30, 2026 · Editorial Policy
Neuroticism is a broad personality trait involving a greater average tendency to experience negative emotions and psychological distress. Substance use disorders are clinical conditions defined by patterns of substance use that cause significant impairment or distress. Research links the two, but the relationship is probabilistic, heterogeneous, and substantially more complex than the claim that a “neurotic personality” causes addiction.
The strongest reading of the evidence is this: higher neuroticism is associated with elevated substance-related risk in some populations and for some outcomes, yet the size and form of that association depend on the substance, the outcome being measured, the personality instrument, co-occurring symptoms, other traits, and the study design. Large meta-analytic work finds that substance use disorders show elevated neuroticism on average, while also showing particularly important links with disinhibition and lower conscientiousness or agreeableness. Prospective evidence suggests that the neuroticism association with later substance problems is real but smaller than its association with anxiety and depressive disorders. Kotov et al. (2010) and Jeronimus et al. (2016) are useful anchors for those conclusions.
This article addresses the reserved NTM-059 question: the relationship between neuroticism, substance use, negative affect, and addiction risk. It does not replace condition-specific assessment, diagnosis, or treatment. For the wider transdiagnostic role of the trait, see Neuroticism and Mental Health: Why the Trait Is a Transdiagnostic Risk Factor. For the personality construct itself, see Neuroticism: What It Is in the Big Five Personality Model.
Neuroticism and Addiction: The Short Answer
Higher neuroticism is associated, on average, with some forms of substance use disorder, problematic use, dependence, relapse, and negative substance-related consequences. The association is neither universal nor equally strong across substances and outcomes. In a major meta-analysis of personality and common mental disorders, substance use disorders were elevated on neuroticism, but their neuroticism association was weaker than the pattern seen for anxiety and depressive disorders; disinhibition and disagreeableness were comparatively more prominent for substance use disorders. Kotov and colleagues’ meta-analysis therefore supports a multi-trait model rather than a single-trait explanation.
Longitudinal evidence points in the same direction. A meta-analysis of 59 longitudinal and prospective studies involving more than 443,000 participants found that neuroticism prospectively predicted a range of mental-health outcomes. The prospective association with substance abuse was considerably smaller than the association with anxiety, depression, and general distress, with reported effect sizes for substance abuse in a relatively modest range. Jeronimus et al. (2016) also found that baseline symptoms and psychiatric history matter when interpreting personality–psychopathology associations.
At the individual level, these findings mean that neuroticism can contribute information about vulnerability without identifying who will or will not develop a substance use disorder. A person can score high on neuroticism and never develop problematic substance use. A person can score low on neuroticism and still develop a substance use disorder through other combinations of genetic, developmental, social, behavioral, psychiatric, and substance-specific risk.
What Neuroticism Means in This Research
Neuroticism is a dimensional Big Five construct. It summarizes relatively enduring individual differences in tendencies such as worry, distress, irritability, sadness, self-consciousness, and vulnerability to feeling overwhelmed. It is a trait: a characteristic pattern estimated across time and situations. The opposite pole is often described as emotional stability. Some modern instruments use a closely related label, Negative Emotionality, rather than Neuroticism.
Trait neuroticism is broader than anxiety and broader than any one psychiatric symptom. It also differs from momentary negative affect. Negative affect refers to unpleasant emotional states or a state-like dimension measured at a particular time or over a short window. A person can have a high trait tendency toward negative emotionality while having a calm afternoon; another person can have low trait neuroticism and still experience intense negative affect during withdrawal, grief, conflict, pain, or an acute crisis.
Measurement matters because studies do not all operationalize the trait in the same way. NEO inventories, the BFI family, IPIP measures, and Eysenck measures overlap but are not interchangeable. Kotov et al. found that the magnitude of disorder associations differed by personality measurement tradition, including weaker associations in studies using Eysenck inventories than NEO measures. A raw score, percentile, or “high neuroticism” label therefore has meaning only within its instrument, scoring method, reference sample, and population. See Neuroticism Test: What It Measures and How to Interpret Results for the measurement layer.
What Addiction and Substance Use Disorder Mean Here
This article uses addiction as a broad public-facing term while keeping clinical claims tied to specific research definitions. In contemporary clinical language, substance use disorder refers to a pattern of recurrent substance use associated with clinically significant impairment or distress. SAMHSA’s current overview describes substance use disorders in terms of recurrent alcohol or drug use that causes clinically significant impairment, including health problems, disability, or failure to meet major responsibilities.
The distinction between use and disorder is essential. Exposure to a substance, occasional use, frequency of use, heavy use, risky use, misuse, craving, dependence measures, diagnostic symptoms, and a formal substance use disorder are different outcomes. Studies of “neuroticism and addiction” often combine literature using several of these endpoints. The evidence becomes misleading when an association with smoking status or drinking quantity is presented as if it were automatically an association with a clinical disorder.
Alcohol illustrates the point clearly. NIAAA’s current clinical overview describes alcohol use disorder under DSM-5-TR as a problematic pattern of alcohol use producing clinically significant impairment or distress, with severity based on the number of diagnostic symptoms. A Big Five score does not establish those criteria.
The present discussion concerns substance-related outcomes. Behavioral conditions such as gambling disorder and problematic gaming have their own evidence bases, constructs, and diagnostic questions; they are outside this article’s canonical intent.
The Best Overall Evidence: Association Exists, but It Is Not a Single-Trait Story
The most influential quantitative synthesis remains the meta-analysis by Kotov et al. (2010), which reviewed 175 studies and produced 66 meta-analyses of higher-order personality traits across anxiety, depressive, and substance use disorders. Diagnostic groups generally showed higher neuroticism and lower conscientiousness. Substance use disorders, however, had a distinctive profile: they were less strongly related to neuroticism than several internalizing conditions and more strongly characterized by disinhibition and disagreeableness.
That pattern immediately weakens the popular idea of one “addictive personality.” Different personality dimensions can contribute through different pathways. Negative emotionality can matter for coping with distress; disinhibition can matter for acting under strong impulses; low conscientiousness can matter for planning, persistence, and behavioral regulation; sensation seeking and extraversion can matter for exposure to rewarding or socially facilitated substance use. Which pathway matters most varies across substances, outcomes, developmental stages, and people.
The longitudinal meta-analysis by Jeronimus et al. (2016) adds another layer. Neuroticism prospectively indexed vulnerability before later common mental disorders, yet substance-abuse associations were much smaller than associations with anxiety and depression. That is exactly the kind of result expected when neuroticism functions as one transdiagnostic vulnerability among many rather than as a substance-specific cause.
Why Neuroticism Is Not an “Addictive Personality”
The phrase “addictive personality” suggests a unitary type: one psychological profile that reliably identifies people destined for addiction. Contemporary personality and addiction research supports a dimensional, multi-factor picture instead. People with substance use disorders are heterogeneous. The same diagnosis can emerge through combinations of reward sensitivity, impulsivity, social exposure, chronic stress, negative affect, trauma, psychiatric symptoms, learned expectancies, genetics, access to substances, and other influences.
Personality findings themselves are heterogeneous. In alcohol research, for example, Lui et al. (2022) synthesized 80 independent samples and found that lower conscientiousness and agreeableness were consistently associated with consumption, risky or hazardous drinking, and negative drinking-related consequences. Extraversion, particularly excitement seeking, was more related to consumption. Neuroticism-related facets such as impulsiveness and angry hostility were more specifically associated with negative consequences.
This facet-level evidence also illustrates a measurement trap. The NEO tradition contains a facet called impulsiveness under Neuroticism, but that facet is not interchangeable with every other construct called impulsivity, disinhibition, or negative urgency. Researchers should identify the instrument and facet model before translating one result into a broad psychological rule. For the NEO facet architecture, see Neuroticism Facets: Anxiety, Anger, Depression, Self-Consciousness, Impulsiveness, and Vulnerability.
Negative Affect: A Mechanism Candidate, Not a Synonym for Neuroticism
One plausible pathway is that people who experience negative emotion more frequently or intensely may be more likely, in some contexts, to use alcohol or drugs for short-term relief. This is often described through coping motives, negative reinforcement, or self-regulation models. The mechanism is psychologically plausible and supported in parts of the literature, but three distinctions are crucial: trait neuroticism is not the same construct as momentary negative affect; reporting a coping motive is not the same as demonstrating that a substance successfully regulates emotion; and a statistical mediation model does not by itself establish a causal chain.
A longitudinal study following young adults from ages 18 to 35 found that changes in coping motives statistically mediated associations between changes in neuroticism and changes in alcohol problems. Littlefield, Sher, and Wood (2010) interpreted coping motives as one mechanism linking personality development with the “maturing out” of problematic drinking. The study is informative because it examined change over time, while still remaining observational evidence rather than an experiment that isolates causation.
Recent ecological-momentary work sharpens the interpretation. In two studies of regularly drinking and cannabis-using young adults, Moss et al. (2026) found that global reports of coping motives were only weakly related to several reported emotion-regulation strategies and were more substantially related to negative emotionality, emotion reactivity, and negative urgency. In other words, a person saying “I use to cope” may partly index a broader negative-emotionality profile rather than a discrete deficit in one regulation skill.
Treatment-period daily-life studies also resist a simple rule. A review of intensive longitudinal studies in treatment-seeking samples found mixed associations between negative affect, craving, and substance use. Strength and direction varied by substance-related outcome, subgroup, context, and time scale. Votaw et al. (2022) therefore provide a useful counterweight to the slogan that negative mood automatically produces craving or use.
Alcohol: Neuroticism Relates More to Problems Than to a Universal Drinking Pattern
Alcohol evidence is especially useful because it separates how much a person drinks from whether drinking becomes harmful. A large individual-participant meta-analysis pooling 72,949 adults across eight cohorts examined transitions in alcohol consumption over time. Higher extraversion and lower conscientiousness predicted movement from moderate to heavy consumption; neuroticism did not emerge as the central prospective predictor of that transition. Hakulinen et al. (2015) therefore show why neuroticism should not be presented as a universal driver of heavy drinking.
At the same time, meta-analytic work across a broader range of alcohol outcomes finds meaningful neuroticism-related signals. Lui et al. (2022) reported that neuroticism facets, particularly impulsiveness and angry hostility in the measures included, were linked more clearly to negative drinking-related consequences than to alcohol consumption itself. This distinction between consumption and consequences is central: traits associated with how often or how much people drink need not be the same traits associated with losing control, experiencing harm, or developing a disorder.
Alcohol treatment data also argue against using neuroticism as a stand-alone relapse marker. A systematic review and meta-analysis of dimensional personality and alcohol treatment outcomes found more consistent relapse associations for novelty seeking, persistence, reward dependence, and cooperativeness within the instruments represented, while studies using other personality measures did not yield a consistent cross-instrument pattern. Foulds et al. (2017) highlight how treatment-outcome conclusions can depend heavily on which personality model is used.
Smoking and Nicotine: A Small Trait Association, With Stronger Signals for Relapse and Cessation
Smoking research offers one of the clearest examples of outcome specificity. An earlier meta-analysis of cross-sectional studies found that smokers scored somewhat higher than nonsmokers on neuroticism, but the effect was small. Munafò, Zetteler, and Clark (2007) emphasized both the association and its modest magnitude.
A later individual-participant meta-analysis combined nine cohorts and almost 80,000 adults. Hakulinen et al. (2015) found that current smoking was associated with higher neuroticism, but prospective initiation was predicted more clearly by higher extraversion and lower conscientiousness. Neuroticism predicted relapse among former smokers and was associated with lower odds of cessation among current smokers. The same trait therefore related differently to starting, currently smoking, stopping, and returning to smoking.
Those findings support a mechanism in which negative emotionality may become especially relevant after a behavior is established, when withdrawal, stress, craving, and learned coping patterns interact. They do not establish that neuroticism causes nicotine dependence in an individual, and they do not make a personality score a cessation prognosis.
Cannabis, Prescription Drug Misuse, and Other Illicit Drugs: Substance-Specific Patterns Matter
Broad labels such as “drug use” can hide major differences among cannabis, stimulants, cocaine, opioids, sedatives, hallucinogens, and prescription misuse. A co-twin-control study by Dash, Martin, and Slutske (2023) examined lifetime use or misuse of multiple drug classes in 980 same-sex twin pairs. At the individual level, familiar associations with neuroticism, agreeableness, and conscientiousness appeared, but within-pair analyses produced a more selective pattern.
In those within-pair analyses, higher neuroticism was associated with prescription drug misuse, while other traits were linked to other drug classes: extraversion with cocaine/crack and stimulant use, openness with cannabis use, and lower agreeableness with cocaine/crack and illicit opioid use. Co-twin designs cannot eliminate every causal ambiguity, yet they reduce some shared familial confounding. The resulting specificity is another reason to avoid statements such as “neuroticism predicts drug addiction” without naming the substance, outcome, sample, and design.
Does High Neuroticism Cause Addiction?
Current evidence supports risk association and vulnerability language more strongly than a simple causal claim. Cross-sectional studies cannot tell whether neuroticism preceded the substance problem. Prospective studies establish temporal ordering more effectively, yet they can still be influenced by unmeasured confounding, prior symptoms, early substance exposure, socioeconomic conditions, family factors, and measurement error. Twin and genetic methods can address some sources of confounding, but they answer population-level questions and come with their own assumptions.
The most defensible causal formulation is therefore conditional: neuroticism may participate in pathways that increase risk for some substance-related outcomes, particularly through negative emotionality, coping motives, reactivity, and comorbid symptoms, while other pathways such as disinhibition, reward seeking, low conscientiousness, social context, and substance availability can be equally or more important. The relative contribution differs across people and outcomes.
Prospective meta-analysis strengthens the vulnerability interpretation without turning it into destiny. Jeronimus et al. (2016) found that elevated neuroticism preceded later common mental-health problems, including a smaller association with substance-abuse outcomes. The effect describes statistical risk in populations, not an individual prediction.
Shared Genetic Liability: Important at the Population Level, Useless as a Personality Diagnosis
Substance use disorders share part of their genetic liability. A genomic structural equation modeling study by Hatoum et al. (2022) analyzed genome-wide summary statistics spanning more than one million participants of European ancestry across problematic alcohol use, problematic tobacco use, cannabis use disorder, and opioid use disorder. The authors identified a shared genetic addiction-risk factor that was genetically associated with risk-taking, neuroticism, executive function, and non-substance psychopathology.
This result does not mean there is an “addiction gene,” a neuroticism gene, or a DNA profile that clinically diagnoses addiction. Genetic correlation concerns partially shared patterns of common genetic variation across large samples. Heritability and genetic association describe population variation under particular study conditions; they do not specify an individual’s outcome, and results from one ancestry composition should not be generalized as if effect estimates were universal across populations.
The genetic findings also reinforce the separation between use and disorder. Hatoum and colleagues modeled problematic substance phenotypes and showed that shared disorder liability retained structure that was not reducible to normative substance use or to general psychopathology. This supports a layered model in which exposure, use, problematic use, and disorder have overlapping but nonidentical determinants.
Can Substance Use Change Neuroticism? The Relationship Can Run Both Ways
Personality is relatively stable, but it can change. Substance-related experiences may coincide with personality change through several possible routes: pharmacologic effects, withdrawal and craving, stressful consequences, changing social environments, remission, treatment, aging, or broader life transitions. Observational evidence supports bidirectional association, while the causal contribution of any one mechanism remains difficult to isolate.
A 2024 systematic review of 55 studies found substantial heterogeneity in personality measures, substance measures, samples, designs, and analyses. Higher substance use was most consistently associated with increases in impulsivity-related traits and, less consistently, neuroticism. Intervention studies were often associated with increases in conscientiousness and self-efficacy and lasting decreases in neuroticism. Juchem et al. (2024) concluded that personality and substance use or disorder may influence each other over time.
Alcohol-specific cohort evidence reaches a compatible but more precise conclusion. In a pooled analysis of six cohorts with nearly 40,000 participants, risky alcohol use was associated over an average 5.6 years with decreasing emotional stability, as well as decreases in agreeableness and conscientiousness. Hakulinen and Jokela (2019) demonstrate longitudinal covariation; because this is observational work, the result still does not prove that alcohol exposure alone caused the personality change.
This distinction matters clinically. A lower neuroticism score after recovery could reflect genuine trait change, reduced withdrawal and psychiatric symptoms, improved sleep, a safer environment, changes in self-perception, measurement state effects, or several processes together. Trait change, mean-level change across a group, individual change, state fluctuation, and symptom improvement should be reported separately.
Neuroticism, Anxiety, and Depression in Substance-Use Research
Neuroticism overlaps statistically with anxiety and depressive symptoms because all involve negative emotional experience, yet the constructs answer different questions. Neuroticism describes a broad personality disposition. Anxiety and depression can refer to states, symptom dimensions, screening scores, syndromes, or clinical disorders depending on the measure and context. A trait score does not establish any of those diagnoses.
This overlap creates both real mechanisms and methodological complications. A study may find that neuroticism predicts substance-related outcomes partly because people with higher neuroticism also report more current anxiety or depressive symptoms. Another study may find an association that remains after adjusting for baseline symptoms. Adjustment itself changes the question: controlling for a construct that partly overlaps with the trait can remove shared variance that may be theoretically meaningful. Results should therefore be read in terms of exactly what was measured and adjusted.
For the dedicated evidence on those relationships, see Neuroticism and Anxiety: What Research Shows and Neuroticism and Depression: What Research Shows. The present page keeps the focus on substance-related outcomes.
Measurement: A “High Neuroticism Score” Does Not Translate Directly Into Addiction Risk
A personality score becomes interpretable only inside a specific measurement system. NEO PI-R and NEO PI-3 neuroticism, NEO-FFI neuroticism, BFI-2 Negative Emotionality, IPIP-based scales, and Eysenck neuroticism measures differ in item content, facet structure, scale length, scoring, and normative resources. Their broad domains overlap, but a raw score from one instrument has no universal conversion into a raw score, percentile, or clinical meaning in another.
The addiction literature adds a second measurement layer because outcomes also vary. Studies may define smoking status, nicotine dependence, binge drinking, alcohol problems, AUD symptoms, cannabis use, prescription misuse, illicit drug exposure, relapse, treatment retention, or formal SUD diagnoses. An association between one personality scale and one of these outcomes cannot automatically be transferred to another.
That is why statements such as “a neuroticism score above X means high addiction risk” are scientifically unsupported unless a validated prediction model has been developed and externally validated for a specified population, instrument, substance, outcome, and time horizon. General Big Five questionnaires are personality measures, not substance-use screening or diagnostic instruments.
Relapse and Recovery: Neuroticism Is Context, Not a Prognosis
The word relapse is often where broad personality claims become exaggerated. Smoking cohorts suggest that neuroticism can predict relapse and lower cessation probability at the group level. Alcohol treatment meta-analysis, however, has not produced a universal neuroticism-relapse rule across personality instruments. Hakulinen et al. (2015) and Foulds et al. (2017) together show why a substance-specific interpretation is more accurate.
Recovery outcomes reflect treatment access and fit, medication when indicated for a specific disorder, social support, housing and safety, psychiatric comorbidity, stress, withdrawal, craving, learned cues, motivation, physical health, and many other factors. Personality can contribute to case formulation—for example, a clinician may pay closer attention to distress-triggered use or coping patterns in someone high in negative emotionality—but a trait score cannot serve as a stand-alone prognosis.
Does Treating Anxiety or Negative Affect “Treat Neuroticism” or Addiction?
Symptom improvement, trait change, and substance-use improvement are separable outcomes. A person may experience reduced anxiety while their neuroticism score changes little. A person may show a lower neuroticism score over months while substance use remains problematic. A person may enter recovery from a substance use disorder while continuing to have a relatively high level of trait negative emotionality.
The 2024 systematic review by Juchem et al. found personality changes during the presence and treatment of substance use problems, including decreases in neuroticism in parts of the intervention literature, but the studies were heterogeneous. Those findings do not establish neuroticism as a disease target or show that lowering a Big Five score is the mechanism required for recovery.
When a substance use disorder is present, diagnosis and treatment belong to the condition-specific clinical pathway. Personality information can supplement that pathway. For alcohol, NIAAA describes evidence-based diagnosis and recovery in terms of alcohol-specific symptoms and care. For substance use disorders more broadly, SAMHSA frames care around the clinical disorder and co-occurring conditions. No Big Five profile substitutes for that assessment.
What High Neuroticism Means for an Individual Who Uses Substances
For an individual, high neuroticism means that a validated personality measure places them relatively higher on a negative-emotionality dimension according to that instrument and reference context. It does not mean that addiction is present, inevitable, or hidden. The useful question is whether there is an actual pattern of substance-related impairment, loss of control, craving, risky use, repeated consequences, or other condition-specific symptoms.
If substance use tends to occur after distress, interpersonal conflict, shame, worry, anger, loneliness, or feeling overwhelmed, that pattern may be clinically meaningful regardless of a Big Five score. The sequence can be examined directly: what emotion occurs, what situation precedes it, what expectation about the substance follows, what behavior occurs, what short-term effect is experienced, and what longer-term consequence follows. This behavioral information is closer to a modifiable mechanism than a broad personality label.
Conversely, a person with low neuroticism can still have severe substance-related problems. Reward seeking, habit learning, social context, pain, withdrawal, availability, impulsivity, occupational exposure, genetic liability, and many other factors can operate with little dependence on trait negative emotionality. Personality should expand the explanatory model rather than narrow it.
How to Read Neuroticism–Addiction Research Without Overclaiming It
A strong interpretation starts by identifying the personality measure. “Neuroticism” measured with a NEO inventory, an Eysenck scale, a brief BFI form, or an IPIP scale is not numerically interchangeable. Next identify the substance outcome. Current smoking, smoking relapse, AUD symptoms, heavy drinking, cannabis use, prescription misuse, and a formal SUD diagnosis answer different questions.
Then identify the study design. Cross-sectional correlation tells us that two variables co-occur. Prospective longitudinal evidence establishes temporal sequence more clearly. Within-person or ecological-momentary evidence examines short-term dynamics. Twin designs reduce some shared familial confounding. Genome-wide genetic correlation describes shared population-level genetic architecture. Randomized intervention evidence addresses causal effects of an intervention. These forms of evidence should not be collapsed into one level of certainty.
Finally, inspect effect size and heterogeneity rather than asking only whether a result reached statistical significance. Very large samples can detect small associations. For prevention or clinical prediction, a small group-level association may have limited individual discrimination. The core question is not simply whether neuroticism is “linked” to addiction, but how strongly, for which outcome, in which population, measured how, and with what plausible alternatives.
Clinical and Practical Implications
The evidence supports using neuroticism as contextual information about vulnerability rather than as a diagnostic shortcut. In research and clinical formulation, higher negative emotionality can flag the possibility that distress, coping motives, psychiatric symptoms, or stress-reactive processes deserve closer assessment. It can also help explain why the same external stressor produces different subjective burdens across people.
At the same time, substance-specific assessment remains primary. A clinician evaluating alcohol problems needs alcohol-use history and AUD criteria; a clinician evaluating nicotine dependence needs tobacco-specific information; opioid, stimulant, sedative, cannabis, and polysubstance problems require their own histories and risk assessment. Personality contributes one layer to a much larger case formulation.
For prevention, the most promising implication is mechanism-focused rather than label-focused. When negative affect reliably precedes use, skills and supports that change the distress-to-use sequence may matter. When impulsivity, social reward, or cue exposure is the dominant pathway, a different formulation is needed. Personality science is most useful when it helps specify pathways rather than assigning identities.
Key Conclusions
Neuroticism is a modern dimensional personality construct, not an addiction diagnosis. Higher neuroticism is associated with some substance-use and substance-disorder outcomes, but the association is smaller and less universal than popular summaries often imply.
Substance use disorders show a multi-trait profile. Disinhibition, conscientiousness, agreeableness, sensation seeking, and other traits can be as important as or more important than neuroticism depending on the substance and outcome. There is no single personality pattern that determines addiction.
Negative affect is one plausible bridge between personality and substance use, especially when substances are used to cope with distress, yet real-time treatment studies show mixed affect–craving and affect–use relationships. Coping motives, negative emotionality, and emotion-regulation strategies overlap without being identical.
Alcohol, nicotine, cannabis, prescription drug misuse, and other drug outcomes show different trait patterns. Longitudinal, twin, genetic, and intervention evidence all contribute distinct information, and none justifies an individual deterministic prediction from a Big Five score.
The relationship can also be bidirectional: personality may shape risk, while persistent substance use, recovery, symptoms, and life changes may coincide with personality change. The best scientific model is therefore developmental, dimensional, and mechanism-specific.
Frequently Asked Questions
Is neuroticism linked to addiction?
Yes, at the population level neuroticism is associated with some substance-use disorders and substance-related outcomes. Meta-analyses also show that the association varies by disorder, substance, outcome, and measurement method. Substance use disorders are especially important examples of multi-trait risk, with disinhibition and lower conscientiousness or agreeableness also contributing.
Does high neuroticism cause addiction?
Evidence supports a vulnerability association more strongly than a simple causal claim. Prospective studies show that neuroticism can precede later substance problems, but confounding, other personality traits, psychiatric symptoms, environment, genetics, and substance-specific pathways also contribute.
Is neuroticism the same as negative affect?
No. Neuroticism is a relatively enduring personality disposition. Negative affect usually describes unpleasant emotional states or a state-like dimension measured over a shorter period. People higher in neuroticism tend to experience more negative affect on average, but the constructs operate at different levels.
Is there an addictive personality?
Research supports multiple personality-related vulnerabilities rather than one unitary personality type that determines addiction. Neuroticism, disinhibition, low conscientiousness, low agreeableness, sensation seeking, and other characteristics show different relationships with different substances and outcomes.
Which substance has the strongest link with neuroticism?
There is no universal ranking. Smoking studies show small cross-sectional neuroticism differences and prospective associations with relapse and cessation. Alcohol findings often place neuroticism closer to negative consequences or specific facets than to consumption itself. Drug-class findings vary further, so substance and outcome need to be specified.
Can neuroticism predict relapse?
In some contexts it contributes to group-level prediction. Neuroticism has predicted smoking relapse in large cohort meta-analysis, while alcohol treatment studies have not established a universal neuroticism-relapse rule. A trait score is therefore contextual information rather than an individual prognosis.
Can addiction increase neuroticism?
Longitudinal studies and systematic reviews show that substance use and personality can change together over time, including associations between heavier or riskier use and higher neuroticism or lower emotional stability. Observational change does not isolate the cause, because symptoms, withdrawal, life stress, recovery, age, and other processes can move at the same time.
Does a high neuroticism score mean I have a substance use disorder?
No. Neuroticism scores describe personality relative to a specific instrument and reference context. Substance use disorder requires substance-specific clinical assessment of symptoms, impairment, distress, and course. A Big Five score cannot diagnose or rule out a substance use disorder.
Can reducing neuroticism prevent addiction?
Current evidence does not establish a general rule that lowering a neuroticism score prevents substance use disorder. Interventions can change symptoms, coping, behavior, and sometimes measured personality traits, but prevention and treatment should target demonstrated substance-specific risks and mechanisms rather than treating neuroticism as a disease.
Related Articles
References
Dash, G. F., Martin, N. G., & Slutske, W. S. (2023). Big Five personality traits and illicit drug use: Specificity in trait-drug associations. Psychological Addictive Behaviors, 37(2), 318–330. https://doi.org/10.1037/adb0000793
Foulds, J., Newton-Howes, G., Guy, N. H., Boden, J. M., & Mulder, R. T. (2017). Dimensional personality traits and alcohol treatment outcome: A systematic review and meta-analysis. Addiction, 112(8), 1345–1357. https://doi.org/10.1111/add.13810
Hakulinen, C., Elovainio, M., Batty, G. D., Virtanen, M., Kivimäki, M., & Jokela, M. (2015). Personality and alcohol consumption: Pooled analysis of 72,949 adults from eight cohort studies. Drug and Alcohol Dependence, 151, 110–114. https://doi.org/10.1016/j.drugalcdep.2015.03.008
Hakulinen, C., Hintsanen, M., Munafò, M. R., Virtanen, M., Kivimäki, M., Batty, G. D., & Jokela, M. (2015). Personality and smoking: Individual-participant meta-analysis of nine cohort studies. Addiction, 110(11), 1844–1852. https://doi.org/10.1111/add.13079
Hakulinen, C., & Jokela, M. (2019). Alcohol use and personality trait change: Pooled analysis of six cohort studies. Psychological Medicine, 49(2), 224–231. https://doi.org/10.1017/S0033291718000636
Hatoum, A. S., Johnson, E. C., Colbert, S. M. C., Polimanti, R., Zhou, H., Walters, R. K., Gelernter, J., Edenberg, H. J., Bogdan, R., & Agrawal, A. (2022). The addiction risk factor: A unitary genetic vulnerability characterizes substance use disorders and their associations with common correlates. Neuropsychopharmacology, 47(10), 1739–1745. https://doi.org/10.1038/s41386-021-01209-w
Jeronimus, B. F., Kotov, R., Riese, H., & Ormel, J. (2016). Neuroticism’s prospective association with mental disorders halves after adjustment for baseline symptoms and psychiatric history, but the adjusted association hardly decays with time: A meta-analysis on 59 longitudinal/prospective studies with 443,313 participants. Psychological Medicine, 46(14), 2883–2906. https://doi.org/10.1017/S0033291716001653
Juchem, C. M., Bendau, A., Bandurski, L. C., Reich, N. J., Baumgardt, S., & Asselmann, E. (2024). Personality changes related to presence and treatment of substance use (disorders): A systematic review. Psychological Medicine, 54(9), 1905–1929. https://doi.org/10.1017/S003329172400093X
Kotov, R., Gamez, W., Schmidt, F., & Watson, D. (2010). Linking “big” personality traits to anxiety, depressive, and substance use disorders: A meta-analysis. Psychological Bulletin, 136(5), 768–821. https://doi.org/10.1037/a0020327
Littlefield, A. K., Sher, K. J., & Wood, P. K. (2010). Do changes in drinking motives mediate the relation between personality change and “maturing out” of problem drinking? Journal of Abnormal Psychology, 119(1), 93–105. https://doi.org/10.1037/a0017512
Lui, P. P., Chmielewski, M., Trujillo, M., Morris, J., & Pigott, T. D. (2022). Linking Big Five personality domains and facets to alcohol (mis)use: A systematic review and meta-analysis. Alcohol and Alcoholism, 57(1), 58–73. https://doi.org/10.1093/alcalc/agab030
Moss, D., Dora, J., Halvorson, M. A., McClain, L., & King, K. M. (2026). Coping motives for alcohol and cannabis use better reflect negative emotionality than emotion regulation deficits in young adults. Journal of Studies on Alcohol and Drugs, 87(3), 544–554. https://doi.org/10.15288/jsad.25-00126
Munafò, M. R., Zetteler, J. I., & Clark, T. G. (2007). Personality and smoking status: A meta-analysis. Nicotine & Tobacco Research, 9(3), 405–413. https://doi.org/10.1080/14622200701188851
National Institute on Alcohol Abuse and Alcoholism. (2025). Alcohol Use Disorder: From Risk to Diagnosis to Recovery. https://www.niaaa.nih.gov/health-professionals-communities/core-resource-on-alcohol/alcohol-use-disorder-risk-diagnosis-recovery
Substance Abuse and Mental Health Services Administration. (2026). Co-Occurring Disorders and Other Health Conditions. https://www.samhsa.gov/substance-use/treatment/co-occurring-disorders
Votaw, V. R., Tuchman, F. R., Piccirillo, M. L., Schwebel, F. J., & Witkiewitz, K. (2022). Examining associations between negative affect and substance use in treatment-seeking samples: A review of studies using intensive longitudinal methods. Current Addiction Reports, 9(4), 445–472. https://doi.org/10.1007/s40429-022-00441-8